LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 77.64 | 84.90 | 8631 | 9245 | 0.9335 | 0.9798 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 77.64 | 84.90 | 971 | 9245 | 0.1050 | 0.4335 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 77.64 | 84.90 | 9851 | 9245 | 1.0655 | 1.0188 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 77.64 | 84.90 | 803 | 9245 | 0.0869 | 0.3938 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 77.64 | 84.90 | 10443 | 9245 | 1.1295 | 1.0363 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 79.34 | 84.90 | 6370 | 9051 | 0.7038 | 0.8984 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 79.34 | 84.90 | 7682 | 9051 | 0.8487 | 0.9519 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 79.34 | 84.90 | 1760 | 9051 | 0.1944 | 0.5684 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 79.34 | 84.90 | 8618 | 9051 | 0.9521 | 0.9855 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 79.34 | 84.90 | 992 | 9051 | 0.1096 | 0.4404 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 79.34 | 84.90 | 10037 | 9051 | 1.1089 | 1.0309 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 79.34 | 84.90 | 947 | 9051 | 0.1046 | 0.4305 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 79.34 | 84.90 | 10650 | 9051 | 1.1766 | 1.0489 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 81.05 | 84.90 | 4333 | 8863 | 0.4888 | 0.7975 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 81.05 | 84.90 | 7633 | 8863 | 0.8611 | 0.9559 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 81.05 | 84.90 | 1257 | 8863 | 0.1418 | 0.4946 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 81.05 | 84.90 | 8479 | 8863 | 0.9566 | 0.9868 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 81.05 | 84.90 | 1010 | 8863 | 0.1139 | 0.4467 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 81.05 | 84.90 | 10273 | 8863 | 1.1590 | 1.0445 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 81.05 | 84.90 | 973 | 8863 | 0.1098 | 0.4386 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 81.05 | 84.90 | 10884 | 8863 | 1.2279 | 1.0622 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 82.75 | 84.90 | 3322 | 8621 | 0.3853 | 0.7334 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 82.75 | 84.90 | 7482 | 8621 | 0.8678 | 0.9579 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 82.75 | 84.90 | 744 | 8621 | 0.0863 | 0.3849 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 82.75 | 84.90 | 8296 | 8621 | 0.9623 | 0.9885 | MN20160318_Q02 | D05 |